Epcoritamab for Relapsed/Refractory EBV+ Post‐Transplant Lymphoproliferative Disorder of DLBCL‐Type

Authors

Sunil Iyengar (ORCID: https://orcid.org/0000-0003-4863-4160)
Dima El‐Sharkawi (ORCID: https://orcid.org/0000-0002-2752-5814)
Li Yuan Chan
Simon O’Connor

Institutions

Royal Marsden NHS Foundation Trust (GB)

Publication Details

Journal: eJHaem
Published: 2025-10-25
DOI: https://doi.org/10.1002/jha2.70156
Primary Topic: Viral-associated cancers and disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Epcoritamab for Relapsed/Refractory EBV+ Post‐Transplant Lymphoproliferative Disorder of DLBCL‐Type

Sunil Iyengar, Dima El‐Sharkawi, Li Yuan Chan, Simon O’Connor

Oct 25, 2025

eJHaem

Viral-associated cancers and disorders

article

Epcoritamab for Relapsed/Refractory EBV+ Post‐Transplant Lymphoproliferative Disorder of DLBCL‐Type

Sunil Iyengar, Dima El‐Sharkawi, Li Yuan Chan, Simon O’Connor

October 25, 2025article en

Abstract

No abstract available for this paper.

eJHaemVol. 6(6)

Royal Marsden NHS Foundation Trust (GB)

Openalex Percentile: Top 58%

Viral-associated cancers and disorders

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Epcoritamab for Relapsed/Refractory EBV+ Post‐Transplant Lymphoproliferative Disorder of DLBCL‐Type — Sunil Iyengar, Dima El‐Sharkawi, et al. · eJHaem (2025) | TGRS Research Map | TGRS